VR Logo

Nyxoah SA (NYXH) download report


Healthcare | Medical Devices & Equipment

Nyxoah SA (NYXH) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions.

IPO Date: 02-Jul-2021

Co-Founder & Chairman: Mr. Robert Taub MBA

CEO & Exec. Director: Mr. Olivier Taelman

Listing: NASDAQ: NYXH

Country: Belgium

Headquarters: Mont-Saint-Guibert,

Website: https://www.nyxoah.com

Key Facts

Market cap: $261.73 Mln

Revenue (TTM): €0.83 Mln

Earnings (TTM): €-28.65 Mln

Cash: €127.83 Mln

Total Debt: €11.81 Mln

Insider's Holding: 46.92%

Liquidity: Low

52 Week range: $8.30 - 37.00

Shares outstanding: 25,797,400

5 Years Aggregate:

  • CFO: €-54.74 Mln
  • EBITDA: €-59.75 Mln
  • Net Profit: €-66.57 Mln

Stock Performance

Time Period Nyxoah SA (NYXH) S&P BSE Sensex S&P Small-Cap 600
YTD-63.61-9.18-18.78
1 month-35.62-4.78-8.00
3 months-56.27-9.66-13.65
1 Year-69.000.81-17.19
3 Years--10.336.10
5 Years--11.345.87
10 Years--11.749.84
As on 01-Jul-2022
Year Nyxoah SA (NYXH) S&P Small-Cap 600 S&P BSE Sensex
202145.5725.2721.99